Getinge (OTCMKTS:GNGBY) Announces Earnings Results

Getinge (OTCMKTS:GNGBY) issued its quarterly earnings results on Wednesday. The company reported $0.32 earnings per share for the quarter, Zacks reports. Getinge had a return on equity of 11.55% and a net margin of 8.20%. The firm had revenue of $875.58 million during the quarter.

Getinge Stock Performance

Shares of Getinge stock opened at $26.52 on Friday. Getinge has a one year low of $18.99 and a one year high of $26.88. The firm has a market capitalization of $7.22 billion, a price-to-earnings ratio of 19.36 and a beta of 0.95. The business has a 50-day simple moving average of $25.17 and a 200 day simple moving average of $22.78. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.31 and a quick ratio of 0.74.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on GNGBY shares. Nordea Equity Research downgraded Getinge from a “buy” rating to a “hold” rating in a research note on Monday, August 31st. Zacks Research cut Getinge from a “strong-buy” rating to a “hold” rating in a research note on Thursday, September 17th. UBS Group started coverage on Getinge in a report on Wednesday, September 2nd. They issued a “hold” rating for the company. Finally, Pareto Securities lowered Getinge from a “strong-buy” rating to a “hold” rating in a research note on Thursday, September 24th. Four analysts have rated the stock with a Hold rating. Based on data from MarketBeat, Getinge has a consensus rating of “Hold”.

Getinge Company Profile

Getinge AB is a Sweden-based medical technology company that develops products and solutions for hospitals, healthcare providers and life sciences organizations. Its offerings are designed to support patient care, surgical procedures, infection prevention and the development and production of pharmaceuticals and other medical products.

The company’s portfolio includes equipment for intensive care and cardiovascular procedures, operating-room systems, surgical instruments, sterilization and disinfection solutions, and products used in laboratories and biopharmaceutical manufacturing.